Julia R. Brown

Julia R. Brown has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Gyre Therapeutics, Inc., Albireo Pharma, Inc. and Cytocom, Inc. In total, 15 filings cover trades dated from 17 March 2009 to 7 June 2018.

The open-market side counts 2 purchases for €41k alongside 4 sales for €517k. Netting one side against the other leaves €476k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants and 6 option exercises.

The newest entry dates from 6 July 2018: an option exercise of €25k, in Albireo Pharma, Inc. The most recent open-market purchase was published on 13 May 2013, 4,927 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.